JP2011501941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011501941A5 JP2011501941A5 JP2010514184A JP2010514184A JP2011501941A5 JP 2011501941 A5 JP2011501941 A5 JP 2011501941A5 JP 2010514184 A JP2010514184 A JP 2010514184A JP 2010514184 A JP2010514184 A JP 2010514184A JP 2011501941 A5 JP2011501941 A5 JP 2011501941A5
- Authority
- JP
- Japan
- Prior art keywords
- leucine
- amine
- acid
- alpha
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95866007P | 2007-07-06 | 2007-07-06 | |
| PCT/IB2008/002490 WO2009007849A2 (en) | 2007-07-06 | 2008-07-07 | Il-23 receptor antagonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011501941A JP2011501941A (ja) | 2011-01-20 |
| JP2011501941A5 true JP2011501941A5 (cg-RX-API-DMAC7.html) | 2011-08-25 |
Family
ID=40229172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010514184A Withdrawn JP2011501941A (ja) | 2007-07-06 | 2008-07-07 | Il−23レセプターのアンタゴニストおよびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100190710A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2288621A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011501941A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101990547A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008273814A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2692037A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL202752A0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009007849A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6077461B2 (ja) | 2011-01-04 | 2017-02-08 | ウニヴェルズィテート チューリッヒ | アルツハイマー病の予防又は治療のためのil−12及び/又はil−23のモジュレーター |
| WO2012112319A1 (en) * | 2011-02-04 | 2012-08-23 | Aegis Therapeutics, Llc | Orally bioavailable peptide drug compositions and methods thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| USRE49026E1 (en) * | 2011-06-14 | 2022-04-12 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| BR112013033617B1 (pt) | 2011-06-27 | 2021-10-26 | Galderma Research & Development | Uso de mrna, método para o diagnóstico de acne, métodos para o monitoramento da progressão ou variação de acne e da eficácia de um tratamento para tratar acne, e de triagem in vitro para a identificação de inibidores de diferenciação de células th17 |
| EP2723890B1 (en) * | 2011-06-27 | 2019-10-09 | Galderma Research & Development | New th17 differentiation markers for acne and uses thereof |
| US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| CZ2012829A3 (cs) * | 2012-11-23 | 2014-06-11 | Biotechnologický Ústav Av Čr, V.V.I. | Polypeptidy pro léčbu autoimunitních chorob založenou na blokaci receptoru pro lidský cytokin IL-23 |
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| WO2016054445A1 (en) | 2014-10-01 | 2016-04-07 | Protagonist Therapeutics, Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| JP2017535527A (ja) | 2014-10-01 | 2017-11-30 | プロタゴニスト セラピューティクス, インコーポレイテッド | 新規のα4β7ペプチド単量体及び二量体拮抗薬 |
| HK1257747A1 (zh) * | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3009834A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| CA3017926C (en) | 2016-03-23 | 2023-10-10 | Protagonist Therapeutics, Inc. | Methods for synthesizing .alpha.4.beta.7 peptide antagonists |
| WO2018022937A1 (en) * | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| EP3681900A4 (en) | 2017-09-11 | 2021-09-08 | Protagonist Therapeutics, Inc. | OPIOID AGONIST PEPTIDES AND THEIR USES |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| CN108618100B (zh) * | 2018-05-10 | 2021-07-27 | 广东天企生物科技有限公司 | 一种具有鲜味和增鲜特性的四肽及其用途 |
| CA3104418A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2020311395A1 (en) | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| MX2022008740A (es) | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| SMT202500254T1 (it) | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| KR20240034224A (ko) | 2021-07-14 | 2024-03-13 | 얀센 바이오테크 인코포레이티드 | 인터류킨-23 수용체의 지질화된 펩티드 억제제 |
| WO2024003313A1 (en) * | 2022-06-30 | 2024-01-04 | Sanofi | New peptides as selective il-23 receptor antagonists |
| WO2026067838A1 (zh) * | 2024-09-30 | 2026-04-02 | 上海瀚辰星泰医药科技有限公司 | 一种多肽化合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000061165A1 (en) * | 1999-04-13 | 2000-10-19 | Smithkline Beecham Corporation | Conserved adhesin motif and methods of use thereof |
| EP1221482B1 (en) * | 1999-09-27 | 2005-12-28 | Chugai Seiyaku Kabushiki Kaisha | Hemopoietin receptor protein, nr12 |
| ATE440864T1 (de) * | 2003-03-10 | 2009-09-15 | Schering Corp | Verwendung von il-23-antagonisten; verwandte reagenzien |
| US20070178520A1 (en) * | 2004-02-27 | 2007-08-02 | Barbara Wolff-Winiski | Screening assay for modulators of interaction between interleukin-12 and/or -23 with their receptors |
| AU2006264567A1 (en) * | 2005-05-05 | 2007-01-11 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
-
2008
- 2008-07-07 JP JP2010514184A patent/JP2011501941A/ja not_active Withdrawn
- 2008-07-07 EP EP08807150A patent/EP2288621A4/en not_active Withdrawn
- 2008-07-07 US US12/666,028 patent/US20100190710A1/en not_active Abandoned
- 2008-07-07 AU AU2008273814A patent/AU2008273814A1/en not_active Abandoned
- 2008-07-07 CA CA2692037A patent/CA2692037A1/en not_active Abandoned
- 2008-07-07 WO PCT/IB2008/002490 patent/WO2009007849A2/en not_active Ceased
- 2008-07-07 CN CN2008800236017A patent/CN101990547A/zh active Pending
-
2009
- 2009-12-15 IL IL202752A patent/IL202752A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Botti et al. | Native chemical ligation using removable Nα-(1-phenyl-2-mercaptoethyl) auxiliaries | |
| JP4081501B2 (ja) | 新規カッパレセプター選択的オピオイドペプチド | |
| JP2013500990A5 (cg-RX-API-DMAC7.html) | ||
| CN101990547A (zh) | Il-23受体拮抗剂以及其应用 | |
| EP2044102A2 (en) | Inhibition of alpha-synuclein aggregation | |
| CA2778236A1 (en) | Gadd45beta targeting agents | |
| US20140107031A1 (en) | Template-fixed peptidomimetics | |
| Chorev et al. | Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists | |
| US20110262508A1 (en) | Antimicrobial compositions, formulations and uses thereof | |
| CN1050721A (zh) | 放射性标记的抗凝血多肽 | |
| JP5519622B2 (ja) | ニューロメジンbおよびソマトスタチンレセプターアゴニスト | |
| JP2007535910A5 (cg-RX-API-DMAC7.html) | ||
| JP2020521784A5 (cg-RX-API-DMAC7.html) | ||
| CN116888146A (zh) | 胰高血糖素样肽-1受体拮抗剂 | |
| JP2008517998A5 (cg-RX-API-DMAC7.html) | ||
| CN1119650A (zh) | 具有胃肠道运动刺激活性的胃动素样多肽 | |
| EP4137502A1 (en) | Vipr2 antagonist peptide | |
| JP2016505514A5 (cg-RX-API-DMAC7.html) | ||
| DeGraw et al. | Stabilized analogs of thymopentin. 1. 4, 5-ketomethylene pseudopeptides | |
| Hill et al. | Enantioselection in peptide bond formation | |
| CN1039126C (zh) | 抗塔基奎宁的三环化合物,及含该化合物的药物组合物 | |
| EP1725580B1 (en) | Isosteric transformation | |
| JP7218906B2 (ja) | 血管機能の検出方法、高血圧症の進行段階を判定する方法、高血圧症の進行段階を判定するためのキット及び高血圧症の治療効果の予測方法 | |
| JP2014515751A (ja) | 成長ホルモン放出因子(grf)類似体およびその使用 | |
| Samant et al. | Norcystine, a new tool for the study of the structure− activity relationship of peptides |